Näytä suppeat kuvailutiedot

dc.contributor.authorFöhr, Tiina
dc.contributor.authorWaller, Katja
dc.contributor.authorViljanen, Anne
dc.contributor.authorSanchez, Riikka
dc.contributor.authorOllikainen, Miina
dc.contributor.authorRantanen, Taina
dc.contributor.authorKaprio, Jaakko
dc.contributor.authorSillanpää, Elina
dc.date.accessioned2021-06-15T08:22:15Z
dc.date.available2021-06-15T08:22:15Z
dc.date.issued2021
dc.identifier.citationFöhr, T., Waller, K., Viljanen, A., Sanchez, R., Ollikainen, M., Rantanen, T., Kaprio, J., & Sillanpää, E. (2021). Does the epigenetic clock GrimAge predict mortality independent of genetic influences : an 18 year follow-up study in older female twin pairs. <i>Clinical Epigenetics</i>, <i>13</i>, Article 128. <a href="https://doi.org/10.1186/s13148-021-01112-7" target="_blank">https://doi.org/10.1186/s13148-021-01112-7</a>
dc.identifier.otherCONVID_97817203
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/76537
dc.description.abstractBackground: Epigenetic clocks are based on DNA methylation (DNAm). It has been suggested that these clocks are useable markers of biological aging and premature mortality. Because genetic factors explain variations in both epigenetic aging and mortality, this association could also be explained by shared genetic factors. We investigated the infuence of genetic and lifestyle factors (smoking, alcohol consumption, physical activity, chronic diseases, body mass index) and education on the association of accelerated epigenetic aging with mortality using a longitudinal twin design. Utilizing a publicly available online tool, we calculated the epigenetic age using two epigenetic clocks, Horvath DNAmAge and DNAm GrimAge, in 413 Finnish twin sisters, aged 63–76 years, at the beginning of the 18-year mortality follow-up. Epigenetic age acceleration was calculated as the residuals from a linear regression model of epigenetic age estimated on chronological age (AAHorvath, AAGrimAge, respectively). Cox proportional hazard models were conducted for individuals and twin pairs. Results: The results of the individual-based analyses showed an increased mortality hazard ratio (HR) of 1.31 (CI95: 1.13–1.53) per one standard deviation (SD) increase in AAGrimAge. The results indicated no signifcant associations of AAHorvath with mortality. Pairwise mortality analyses showed an HR of 1.50 (CI95: 1.02–2.20) per 1 SD increase in AAGrimAge. However, after adjusting for smoking, the HR attenuated substantially and was statistically non-signifcant (1.29; CI95: 0.84–1.99). Similarly, in multivariable adjusted models the HR (1.42–1.49) was non-signifcant. In AAHorvath, the non-signifcant HRs were lower among monozygotic pairs in comparison to dizygotic pairs, while in AAGrimAge there were no systematic diferences by zygosity. Further, the pairwise analysis in quartiles showed that the increased within pair diference in AAGrimAge was associated with a higher all-cause mortality risk. Conclusions: In conclusion, the fndings suggest that DNAm GrimAge is a strong predictor of mortality independent of genetic infuences. Smoking, which is known to alter DNAm levels and is built into the DNAm GrimAge algorithm, attenuated the association between epigenetic aging and mortality risk.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherBiomed Central
dc.relation.ispartofseriesClinical Epigenetics
dc.rightsCC BY 4.0
dc.subject.otherbiological age
dc.subject.otherDNA methylation
dc.subject.otherepigenetic clock
dc.subject.othermortality
dc.subject.othertwins
dc.titleDoes the epigenetic clock GrimAge predict mortality independent of genetic influences : an 18 year follow-up study in older female twin pairs
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202106153738
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineGerontologia ja kansanterveysfi
dc.contributor.oppiaineLiikuntalääketiedefi
dc.contributor.oppiaineGerontologian tutkimuskeskusfi
dc.contributor.oppiaineHyvinvoinnin tutkimuksen yhteisöfi
dc.contributor.oppiaineGerontology and Public Healthen
dc.contributor.oppiaineSports and Exercise Medicineen
dc.contributor.oppiaineGerontology Research Centeren
dc.contributor.oppiaineSchool of Wellbeingen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1868-7075
dc.relation.volume13
dc.type.versionpublishedVersion
dc.rights.copyright© 2021 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysokuolleisuus
dc.subject.ysoikääntyminen
dc.subject.ysoepigenetiikka
dc.subject.ysoDNA-metylaatio
dc.subject.ysokaksostutkimus
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p5003
jyx.subject.urihttp://www.yso.fi/onto/yso/p5056
jyx.subject.urihttp://www.yso.fi/onto/yso/p24631
jyx.subject.urihttp://www.yso.fi/onto/yso/p38350
jyx.subject.urihttp://www.yso.fi/onto/yso/p18525
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1186/s13148-021-01112-7
jyx.fundinginformationThis work was supported by the Academy of Finland (grant 251723 to TR, grants 265240, 263278, 308248, 312073, 336823 to JK, 297908 and 251316 to MO), EC MC ITN Project EPITRAIN (JK and MO), University of Helsinki Research Funds (MO), the Sigrid Juselius Foundation (to JK and MO), the Juho Vainio Foundation (ES), and the Yrjö Jahnsson Foundation (ES).
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0